Health Canada officials to hold a technical briefing regarding a decision for the neonicotinoid imidacloprid
Media advisory
May 18, 2021, OTTAWA, ON - Officials from Health Canada will hold a technical briefing to discuss the final re-evaluation decision for the neonicotinoid imidacloprid.
Officials will be available to answer questions from the media following their remarks.
Date
May 19, 2021
Time
2:00 PM (EDT)
Location
The technical briefing will be held by teleconference only.
Toll-free (Canada/US) dial-in number:
1-866-206-0153
Local dial-in number:
613-954-9003
Passcode: 2112476#
NOTE: To obtain the briefing material under embargo, please RSVP by email at
hc.media.sc@canada.ca.
Contacts
Media Relations
Health Canada
613-957-2983
hc.media.sc@canada.ca
Report a problem or mistake on this page
- Date modified: